Ann: ResApp Signs MOU to Develop Respiratory App for Consumers, page-147

Australia’s ResApp To Develop Respiratory App for Consumers
By Iselle Chua -
June 18, 2020


Photo by Gilles Lambert on Unsplash
ResApp Health Ltd, an ASX-listed digital health company, has signed a deal with global health products manufacturer RB to develop a smartphone app for consumers.

In a disclosure, ResApp said the app will utilise the company’s cough-based algorithms to identify different respiratory conditions and provide recommended next steps.


ResApp and RB have agreed to exclusively work together to build and test a prototype app for consumers to self-assess, or assess with the assistance of a pharmacist, their respiratory symptoms.

The company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware.

Its regulatory-approved and clinically-validated products include ResAppDx-EU, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care settings.

It also owns SleepCheck, an at-home sleep apnoea screening app for consumers to self-assess their risk of sleep apnoea. – BusinessNewsAsia.com

• TAGS
• ASX
• ResApp
• Respiratory App

LEAVE A REPLY


WordPress Gallery

Crypto.com Completes Infrastructure Upgrade of Exchange

• NYSE-listed Cryolife To O

BusinessNewsAsia.com is an online publication that focuses on business news, investments news, finance and economic news around Asia and around the world. It also features breaking stories and trending events happening around the across the globe.


© BusinessNewsAsia.com All Rights Reserved 2016